Search

Wei Xu Phones & Addresses

  • Commack, NY
  • Pottstown, PA

Professional Records

Medicine Doctors

Wei Xu Photo 1

Wei A. Xu

View page
Specialties:
Family Medicine
Work:
Gaithersburg Family Medicine
604 S Frederick Ave STE 200, Gaithersburg, MD 20877
(240) 404-6423 (phone), (240) 404-6426 (fax)
Education:
Medical School
The Second Military Med Univ, Shanghai City, Shanghai, China
Graduated: 1989
Procedures:
Electrocardiogram (EKG or ECG)
Pulmonary Function Tests
Vaccine Administration
Conditions:
Abnormal Vaginal Bleeding
Acne
Acute Bronchitis
Allergic Rhinitis
Anemia
Languages:
Chinese
English
Description:
Dr. Xu graduated from the The Second Military Med Univ, Shanghai City, Shanghai, China in 1989. She works in Gaithersburg, MD and specializes in Family Medicine.
Wei Xu Photo 2

Wei Min Xu

View page
Specialties:
Family Medicine
Work:
Kaiser Permanente Medical GroupKaiser Permanente Sacramento Medical Center
2345 Fair Oaks Blvd, Sacramento, CA 95825
(916) 973-5000 (phone), (916) 480-6424 (fax)
Education:
Medical School
Guangzhou Med Coll, Guangzhou City, Guangdong, China
Graduated: 1982
Procedures:
Electrocardiogram (EKG or ECG)
Hearing Evaluation
Vaccine Administration
Conditions:
Acute Pharyngitis
Acute Sinusitis
Acute Upper Respiratory Tract Infections
Bronchial Asthma
Contact Dermatitis
Languages:
English
Description:
Dr. Xu graduated from the Guangzhou Med Coll, Guangzhou City, Guangdong, China in 1982. He works in Sacramento, CA and specializes in Family Medicine.
Wei Xu Photo 3

Wei Xu

View page
Specialties:
Physical Medicine & Rehabilitation
Work:
Bacharach Rehab MedicineBacharach Institute For Rehabilitation
61 W Jimmie Leeds Rd, Pomona, NJ 08240
(609) 748-5380 (phone), (609) 652-8749 (fax)
Education:
Medical School
The Second Military Med Univ, Shanghai City, Shanghai, China
Graduated: 1985
Languages:
English
Spanish
Description:
Dr. Xu graduated from the The Second Military Med Univ, Shanghai City, Shanghai, China in 1985. He works in Pomona, NJ and specializes in Physical Medicine & Rehabilitation. Dr. Xu is affiliated with Atlanticare Regional Medical Center and Shore Medical Center.
Wei Xu Photo 4

Wei Xu

View page
Specialties:
Physical Medicine & Rehabilitation
Work:
Hartford Orthopedic Medicine
100 Wl St STE 1B, Hartford, CT 06103
(860) 249-4466 (phone), (860) 249-4469 (fax)
Education:
Medical School
Capital Univ of Med Scis, Training Ctr of Gen Prac, Beijing City, China
Graduated: 1995
Languages:
English
Spanish
Description:
Dr. Xu graduated from the Capital Univ of Med Scis, Training Ctr of Gen Prac, Beijing City, China in 1995. He works in Hartford, CT and specializes in Physical Medicine & Rehabilitation.
Wei Xu Photo 5

Wei H. Xu

View page
Specialties:
Internal Medicine, Holistic Medicine
Work:
Doctors On-Call
6010 Bay Pkwy STE 901, Brooklyn, NY 11204
(718) 238-2100 (phone), (718) 748-0863 (fax)
Languages:
English
Description:
Ms. Xu works in Brooklyn, NY and specializes in Internal Medicine and Holistic Medicine. Ms. Xu is affiliated with Maimonides Medical Center, Mount Sinai Beth Israel Brooklyn Medical Center and New York Methodist Hospital.
Wei Xu Photo 6

Wei Ji Xu

View page
Specialties:
Anesthesiology
Education:
Jinzhou Medical College (1986)
Wei Xu Photo 7

Wei Xu

View page
Specialties:
Physical Medicine & Rehabilitation
Education:
Capital Medical College, Beijing (1995)

License Records

Wei Xu

License #:
MTL001430 - Active
Category:
MEDICINE
Issued Date:
Apr 22, 2013
Expiration Date:
Jul 31, 2017
Type:
MEDICAL TRAINING LICENSE I(B)

Lawyers & Attorneys

Wei Xu Photo 8

Wei Xu - Lawyer

View page
Licenses:
Texas - Eligible To Practice In Texas 2011
Education:
Southern Methodist University, Dedman School of Law
Languages:
Mandarin
Wei Xu Photo 9

Wei Xu - Lawyer

View page
ISLN:
1000218260
Admitted:
2016

Resumes

Resumes

Wei Xu Photo 10

Wei Xu pennsylvania

View page
Work:
Olympus America Inc

2005 to 2000
Sr. Software QA Engineer

Computer Associates
Islandia, NY
2002 to 2004
Software Engineer

Computer Associates
Islandia, NY
2001 to 2002
Programmer

Computer Associates
Islandia, NY
1998 to 2001
Quality Assurance Engineer

Education:
University of Houston
Houston, TX
B.S. in Computer Science

Skills:
Databases<br/>SQL<br/>Testing

Business Records

Name / Title
Company / Classification
Phones & Addresses
Wei Xu
Project Manager Security And Risk Management
Mastercard Incorporated
Business Services
2000 Purchase St, Purchase, NY 10577
Wei Xu
Project Manager Security And Risk Management
MASTERCARD INCORPORATED
Credit Card Service
Mastercard Int'l, Purchase, NY 10577
2000 Purchase St, Purchase, NY 10577
(914) 249-2000
Wei Angela Xu
Ward & Xu, Pllc
Wei Xu
NEWARK 2005, LLC
Wei Xu
Project Manager Security And Risk Management
Mastercard Incorporated
Business Services
2000 Purchase St, Purchase, NY 10577

Publications

Isbn (Books And Publications)

Machine Learning Techniques for Multimedia

View page
Author

Wei Xu

ISBN #

0387699384

Us Patents

Crystalline Forms Of An Integrin Receptor Antagonist

View page
US Patent:
6509347, Jan 21, 2003
Filed:
Jun 11, 2002
Appl. No.:
10/167678
Inventors:
Wei Xu - North Wales PA
Yaling Wang - Westfield NJ
Assignee:
Merck Co., Inc. - Rahway NJ
International Classification:
A61K 314375
US Classification:
514300, 546122
Abstract:
The present invention relates to novel crystalline forms of the integrin v3 antagonist 3-{2-oxo-3-[3-(5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yl)-propyl]imidazolidin-1-yl}-3(S)-(6-methoxy-pyridin-3-yl)-propionic acid.

Sodium Salt Of An Hiv Integrase Inhibitor

View page
US Patent:
6924282, Aug 2, 2005
Filed:
Aug 14, 2002
Appl. No.:
10/218537
Inventors:
Neville J. Anthony - Hatfield PA, US
Wei Xu - North Wales PA, US
John V. Lepore - Marlboro NJ, US
Amar J. Mahajan - Piscataway NJ, US
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C07D417/14
A61K031/541
A61P031/18
US Classification:
5142222, 544 3
Abstract:
A sodium salt of Compound A is disclosed, wherein Compound A is of formula: Compound A is an HIV integrase inhibitor useful for preventing or treating HIV infection, for delaying the onset of AIDS, and for treating AIDS.

Phosphoric Acid Salt Of An Integrin Receptor Antagonist

View page
US Patent:
20050101593, May 12, 2005
Filed:
Oct 1, 2001
Appl. No.:
10/398366
Inventors:
Robert Meissner - Schwenksville PA, US
Wei Xu - North Wales PA, US
International Classification:
A61K031/55
C07D487/02
US Classification:
514215000, 540577000
Abstract:
The phosphoric acid salt of 3-(2-methoxy-pyrimidin-5-yl)-5-oxo-9-(6,7,8,9-tetrahydro-5H-pyrido[2,3-b]azepin-2-yl)-nonanoic acid is a potent antagonist of the integrin αvβ3 receptor and is useful for the prevention and/or treatment of osteoporosis and vascular restenosis, as well as conditions associated with excessive angiogenesis, such as macular degeneration, diabetic retinopathy, atherosclerosis, inflammatory arthritis, cancer, and metastatic tumor growth. The invention also relates to a process for the preparation of the novel salt as well as pharmaceutical compositions and methods of use.

Mannitol Formulation For Integrin Receptor Antagonist

View page
US Patent:
20060030581, Feb 9, 2006
Filed:
Sep 16, 2003
Appl. No.:
10/527605
Inventors:
Laura DeBusi - Schwenksville PA, US
Sami Karaborni - Lansdale PA, US
Bozen Matuszewska - North Wales PA, US
Adama Procopio - Cinnaminson PA, US
Wei Xu - North Wales PA, US
Chia-Yi Yang - North Wales PA, US
International Classification:
A61K 31/4745
US Classification:
514300000
Abstract:
Disclosed are pharmaceutical compositions of an integrin αvβ3 receptor antagonist containing mannitol as the binding agent. The compositions are prepared by wet granulation or direct compression tablet formulation. These pharmaceutical formulations are useful for inhibiting bone resorption associated with osteoporosis, metastatic bone disease, hypercalcemia of malignancy, and Paget's disease.

Pharmaceutical Composition Containing An Anti-Nucleating Agent

View page
US Patent:
20080118559, May 22, 2008
Filed:
Dec 2, 2005
Appl. No.:
11/792190
Inventors:
Maria T. Cruanes - Lansdale PA, US
Wei Xu - North Wales PA, US
Laura M. Artino - Cakhurst NJ, US
Honggang Zhu - Collegeville PA, US
International Classification:
A61K 31/519
A61K 31/513
A61K 9/20
US Classification:
424464, 5142595, 514269
Abstract:
Pharmaceutical compositions suitable for oral administration in solid dosage forms are described. The compositions comprise an effective amount of a drug compound in the form of a salt, wherein the drug salt is characterized by conversion to a less soluble form of the drug compound under certain pH conditions, and an anti-nucleating agent.

Formulations For Cgrp Receptor Antagonists

View page
US Patent:
20210330660, Oct 28, 2021
Filed:
Dec 7, 2020
Appl. No.:
17/114169
Inventors:
Majid Mahjour - Schwenksville PA, US
Leonardo R. Allain - Lansdale PA, US
Sutthilug Sotthivirat - Lansdale PA, US
Russell G. Maus - Collegeville PA, US
Rebecca Nofsinger - Lansdale PA, US
Lisa Lupton - South San Francisco CA, US
Wei Xu - North Wales PA, US
Francis Flanagan - North Wales PA, US
International Classification:
A61K 31/4545
A61K 47/10
A61K 9/08
Abstract:
The instant invention relates to liquid pharmaceutical compositions containing CGRP receptor antagonists. The CGRP receptor antagonist liquid pharmaceutical compositions of the instant invention are alcohol-free, low volume liquid pharmaceutical compositions that can be taken without water for the treatment of migraine headache.

Tablet Formulation For Cgrp Active Compounds

View page
US Patent:
20210085612, Mar 25, 2021
Filed:
Dec 3, 2020
Appl. No.:
17/110398
Inventors:
- Rahway NJ, US
Leonardo Resende Allain - Lansdale PA, US
W. Mark Eickhoff - Lansdale PA, US
Craig B. Ikeda - Harleysville PA, US
Chad D. Brown - Quakertown PA, US
Rebecca Nofsinger - Lansdale PA, US
Melanie Marota - Lansdale PA, US
Lisa Lupton - South San Francisco CA, US
Paresh B. Patel - Langhome PA, US
Hanmi Xi - Furlong PA, US
Wei Xu - North Wales PA, US
International Classification:
A61K 9/20
A61K 31/437
A61K 31/4545
Abstract:
The present invention is directed to compositions comprising an extrudate or solid solution of a compound, or a salt thereof, of Formula I (API):wherein “R” is independently —H or —F, in a water-soluble polymer matrix which further comprises a disintegration system allowing a tablet made therefrom to rapidly disintegrate in the environment in which the API is to be released.

Tablet Formulation For Cgrp Active Compounds

View page
US Patent:
20190209478, Jul 11, 2019
Filed:
Nov 2, 2018
Appl. No.:
16/178641
Inventors:
- Rahway NJ, US
Leonardo Resende Allain - Lansdale PA, US
W. Mark Eickhoff - Lansdale PA, US
Craig B. Ikeda - Harleysville PA, US
Chad D. Brown - Quakertown PA, US
Rebecca Nofsinger - Lansdale PA, US
Melanie Marota - Lansdale PA, US
Lisa Lupton - South San Francisco CA, US
Paresh B. Patel - Langhorne PA, US
Hanmi Xi - Furlong PA, US
Wei Xu - North Wales PA, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 9/20
A61K 31/4545
A61K 31/437
Abstract:
The present invention is directed to compositions comprising an extrudate or solid solution of a compound, or a salt thereof, of Formula I (API):wherein “R” is independently —H or —F, in a water-soluble polymer matrix which further comprises a disintegration system allowing a tablet made therefrom to rapidly disintegrate in the environment in which the API is to be released.
Wei Xu from Commack, NY Get Report